BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 32712502)

  • 1. Structural basis of CRISPR-Cas Type III prokaryotic defence systems.
    Molina R; Sofos N; Montoya G
    Curr Opin Struct Biol; 2020 Dec; 65():119-129. PubMed ID: 32712502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back.
    Koonin EV; Makarova KS
    Genome Biol Evol; 2017 Oct; 9(10):2812-2825. PubMed ID: 28985291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.
    Koonin EV; Makarova KS
    RNA Biol; 2013 May; 10(5):679-86. PubMed ID: 23439366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting CRISPR/Cas: interference mechanisms and applications.
    Richter H; Randau L; Plagens A
    Int J Mol Sci; 2013 Jul; 14(7):14518-31. PubMed ID: 23857052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
    van der Oost J; Westra ER; Jackson RN; Wiedenheft B
    Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
    Borges AL; Davidson AR; Bondy-Denomy J
    Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
    Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.
    Barrangou R; Marraffini LA
    Mol Cell; 2014 Apr; 54(2):234-44. PubMed ID: 24766887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
    Liu T; Pan S; Li Y; Peng N; She Q
    Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
    Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis.
    Shmakov SA; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5307-E5316. PubMed ID: 29784811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
    Bhaya D; Davison M; Barrangou R
    Annu Rev Genet; 2011; 45():273-97. PubMed ID: 22060043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas systems in oral microbiome: From immune defense to physiological regulation.
    Gong T; Zeng J; Tang B; Zhou X; Li Y
    Mol Oral Microbiol; 2020 Apr; 35(2):41-48. PubMed ID: 31995666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers.
    Pourcel C; Touchon M; Villeriot N; Vernadet JP; Couvin D; Toffano-Nioche C; Vergnaud G
    Nucleic Acids Res; 2020 Jan; 48(D1):D535-D544. PubMed ID: 31624845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas Systems in Prokaryotes.
    Burmistrz M; Pyrć K
    Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.